Your search for tofacitinib returned 3 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Mital Patel, PharmD remove
Older than 2 years remove

Your search for tofacitinib returned 3 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

New Data Shows Tofacitinib Effective for Plaque Psoriasis

Pfizer announced results from two Phase 3 studies from the Oral treatment Psoriasis Trials (OPT) program for tofacitinib citrate in adults with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.
Drugs in the Pipeline

FDA to Review New Xeljanz Formulation for Rheumatoid Arthritis

Pfizer announced that the Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for Xeljanz (tofacitinib citrate) 11mg once daily modified release tablets for the treatment of moderate to severe rheumatoid arthritis in patients with inadequate response or intolerance to methotrexate.
Drugs in the Pipeline

Xeljanz sNDA Accepted for Review for Plaque Psoriasis

The Food and Drug Administration (FDA) has accepted for review the sNDA for Xeljanz (tofacitinib citrate; Pfizer) 5mg and 10mg tablets for the treatment of adults with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.